Mark L. Berch

Array ( [id] => 322654 [patent_doc_number] => 07517887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/964236 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 17317 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517887.pdf [firstpage_image] =>[orig_patent_app_number] => 10964236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 289162 [patent_doc_number] => 07547777 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Penam crystals and process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/574279 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4240 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547777.pdf [firstpage_image] =>[orig_patent_app_number] => 10574279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142530 [patent_doc_number] => 07692003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Penicillin crystals and process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/574278 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2966 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/692/07692003.pdf [firstpage_image] =>[orig_patent_app_number] => 10574278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918732 [patent_doc_number] => 20050096293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Analogs of nitrobenzylthioinosine' [patent_app_type] => utility [patent_app_number] => 10/958681 [patent_app_country] => US [patent_app_date] => 2004-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14099 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096293.pdf [firstpage_image] =>[orig_patent_app_number] => 10958681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643273 [patent_doc_number] => 20060281728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => '3-Substituted beta-lactamyl vasopressin v1a antagonists' [patent_app_type] => utility [patent_app_number] => 10/573732 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25258 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281728.pdf [firstpage_image] =>[orig_patent_app_number] => 10573732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637920 [patent_doc_number] => 07125874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'Optically active 5H-pyrrolo[3,4-b] pyrazine derivative, its preparation and pharmaceutical compositions containing same' [patent_app_type] => utility [patent_app_number] => 10/951844 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1740 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125874.pdf [firstpage_image] =>[orig_patent_app_number] => 10951844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7607500 [patent_doc_number] => 07098216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-29 [patent_title] => 'Thiazolopyrimidines useful as TNFα inhibitors' [patent_app_type] => utility [patent_app_number] => 10/952077 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5887 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/098/07098216.pdf [firstpage_image] =>[orig_patent_app_number] => 10952077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638105 [patent_doc_number] => 20060069079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Stable amorphous cefdinir' [patent_app_type] => utility [patent_app_number] => 10/821695 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 4564 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069079.pdf [firstpage_image] =>[orig_patent_app_number] => 10821695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011452 [patent_doc_number] => 20050065168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process' [patent_app_type] => utility [patent_app_number] => 10/952151 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9956 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065168.pdf [firstpage_image] =>[orig_patent_app_number] => 10952151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658869 [patent_doc_number] => 07105665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/947708 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27683 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105665.pdf [firstpage_image] =>[orig_patent_app_number] => 10947708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602985 [patent_doc_number] => 20060293330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Hiv replication inhibiting purine derivatives' [patent_app_type] => utility [patent_app_number] => 10/573364 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29603 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293330.pdf [firstpage_image] =>[orig_patent_app_number] => 10573364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939777 [patent_doc_number] => 20050113340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => '2-Aminopurine analogs having HSP90-inhibiting activity' [patent_app_type] => utility [patent_app_number] => 10/946645 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48180 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113340.pdf [firstpage_image] =>[orig_patent_app_number] => 10946645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105161 [patent_doc_number] => 20050107343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Pyrrolopyrimidines and related analogs as HSP90-inhibitors' [patent_app_type] => utility [patent_app_number] => 10/945851 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46164 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107343.pdf [firstpage_image] =>[orig_patent_app_number] => 10945851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145762 [patent_doc_number] => 20050119282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Pyrazolopyrimidines and related analogs as HSP90-inhibitors' [patent_app_type] => utility [patent_app_number] => 10/946637 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35798 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119282.pdf [firstpage_image] =>[orig_patent_app_number] => 10946637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939776 [patent_doc_number] => 20050113339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Triazolopyrimidines and related analogs as HSP90-inhibitors' [patent_app_type] => utility [patent_app_number] => 10/946628 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25460 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113339.pdf [firstpage_image] =>[orig_patent_app_number] => 10946628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918745 [patent_doc_number] => 20050096306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Cephem compounds' [patent_app_type] => utility [patent_app_number] => 10/942916 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27977 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096306.pdf [firstpage_image] =>[orig_patent_app_number] => 10942916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 386701 [patent_doc_number] => 07304070 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => 'A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/942582 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27847 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/304/07304070.pdf [firstpage_image] =>[orig_patent_app_number] => 10942582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 526544 [patent_doc_number] => 07183268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => '2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents' [patent_app_type] => utility [patent_app_number] => 10/942314 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10294 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183268.pdf [firstpage_image] =>[orig_patent_app_number] => 10942314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939792 [patent_doc_number] => 20050113355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Cefdinir pyridine salt' [patent_app_type] => utility [patent_app_number] => 10/939908 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2791 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113355.pdf [firstpage_image] =>[orig_patent_app_number] => 10939908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205831 [patent_doc_number] => 20070027313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Process for producing 3-chloromethyl-3-cephem derivative' [patent_app_type] => utility [patent_app_number] => 10/570248 [patent_app_country] => US [patent_app_date] => 2004-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11136 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027313.pdf [firstpage_image] =>[orig_patent_app_number] => 10570248 [rel_patent_id] =>[rel_patent_doc_number] =>)